Back to resultsFurosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
Primary Purpose
Bronchiolitis
Status
Completed
Phase
Phase 3
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
furosemide
Sponsored by
About this trial
This is an interventional supportive care trial for Bronchiolitis focused on measuring furosemide, inhalation, dyspnea, spirometry, mustard gas, bronchiolitis, sulfur mustard
Eligibility Criteria
Inclusion Criteria:
- Patients with a history of exposure to sulfur mustard with a complaint of dyspnea
Exclusion Criteria:
- A contraindication for furosemide use;
- An accompanying disease in which other drugs effective for dyspnea were used
Sites / Locations
- RCCI
Outcomes
Primary Outcome Measures
effect of furosemid inhalation on dyspnea
Secondary Outcome Measures
Full Information
NCT ID
NCT00512811
First Posted
August 7, 2007
Last Updated
August 7, 2007
Sponsor
Baqiyatallah Medical Sciences University
1. Study Identification
Unique Protocol Identification Number
NCT00512811
Brief Title
Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
Official Title
Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2007
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Baqiyatallah Medical Sciences University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bronchiolitis
Keywords
furosemide, inhalation, dyspnea, spirometry, mustard gas, bronchiolitis, sulfur mustard
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
furosemide
Primary Outcome Measure Information:
Title
effect of furosemid inhalation on dyspnea
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
32 Years
Maximum Age & Unit of Time
83 Years
Eligibility Criteria
Inclusion Criteria:
Patients with a history of exposure to sulfur mustard with a complaint of dyspnea
Exclusion Criteria:
A contraindication for furosemide use;
An accompanying disease in which other drugs effective for dyspnea were used
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mostafa Ghanei, MD
Organizational Affiliation
Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
Official's Role
Study Chair
Facility Information:
Facility Name
RCCI
City
Tehran
Country
Iran, Islamic Republic of
12. IPD Sharing Statement
Learn more about this trial
Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
We'll reach out to this number within 24 hrs